Uterine artery embolization (UAE) for diffuse leiomyomatosis of the uterus: Clinical and imaging results

Jieun Koh, Man Deuk Kim, Dae Chul Jung, Myungsu Lee, Mu Sook Lee, Jong Yun Won, Do Yun Lee, Sung Il Park, Kwang Hun Lee

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: The aim of the current study was to evaluate the efficacy of uterine artery embolization (UAE) in the management of diffuse uterine leiomyomatosis with mid-term follow-up. Materials and methods: All patients who underwent UAE between 2008 and 2010 for symptomatic fibroids were analyzed. Among 360 cases, a total of 7 patients with diffuse uterine leiomyomatosis diagnosed based on MRI were included in this retrospective study. Patient ages ranged from 29 to 38 (mean 32.7) years. The median follow-up period was 16 (range; 6-31) months. The embolic agent was non-spherical polyvinyl alcohol particles. All patients underwent follow-up MRI at 3 months after UAE. Uterine volumes were calculated using MRI. Menorrhagia symptom changes were assessed at mid-term follow-up. Results: There were no technical failures to catheterize the uterine artery and no adverse events requiring therapy after UAE. Contrast-enhanced MRI showed complete necrosis of the leiomyomatous nodules in 5 patients (71%) 3 months after embolization. Two patients (28%) showed mostly leiomyomatous nodules that were necrotized, some of which were still viable. All 7 patients with menorrhagia had improvement of symptoms at the mid-term follow-up. The initial mean uterine volume was 601.30 ± 533.92 cm 3 and was decreased to a mean of 278.81 ± 202.70 cm 3 at 3 months follow-up, for a mean uterus volume reduction rate of 50.1% (p < 0.05). One patient became pregnant 5 months after UAE treatment. Conclusion: UAE was a highly effective treatment for diffuse uterine leiomyomatosis with mid-term durability and may be a valuable alternative to hysterectomy.

Original languageEnglish
Pages (from-to)2726-2729
Number of pages4
JournalEuropean Journal of Radiology
Volume81
Issue number10
DOIs
Publication statusPublished - 2012 Oct 1

Fingerprint

Leiomyomatosis
Uterine Artery Embolization
Uterus
Menorrhagia
Polyvinyl Alcohol
Uterine Artery
Leiomyoma
Hysterectomy
Necrosis
Therapeutics
Retrospective Studies

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Koh, Jieun ; Kim, Man Deuk ; Jung, Dae Chul ; Lee, Myungsu ; Lee, Mu Sook ; Won, Jong Yun ; Lee, Do Yun ; Park, Sung Il ; Lee, Kwang Hun. / Uterine artery embolization (UAE) for diffuse leiomyomatosis of the uterus : Clinical and imaging results. In: European Journal of Radiology. 2012 ; Vol. 81, No. 10. pp. 2726-2729.
@article{5c8eee27d0664708abc47f04ae8ebf8c,
title = "Uterine artery embolization (UAE) for diffuse leiomyomatosis of the uterus: Clinical and imaging results",
abstract = "Purpose: The aim of the current study was to evaluate the efficacy of uterine artery embolization (UAE) in the management of diffuse uterine leiomyomatosis with mid-term follow-up. Materials and methods: All patients who underwent UAE between 2008 and 2010 for symptomatic fibroids were analyzed. Among 360 cases, a total of 7 patients with diffuse uterine leiomyomatosis diagnosed based on MRI were included in this retrospective study. Patient ages ranged from 29 to 38 (mean 32.7) years. The median follow-up period was 16 (range; 6-31) months. The embolic agent was non-spherical polyvinyl alcohol particles. All patients underwent follow-up MRI at 3 months after UAE. Uterine volumes were calculated using MRI. Menorrhagia symptom changes were assessed at mid-term follow-up. Results: There were no technical failures to catheterize the uterine artery and no adverse events requiring therapy after UAE. Contrast-enhanced MRI showed complete necrosis of the leiomyomatous nodules in 5 patients (71{\%}) 3 months after embolization. Two patients (28{\%}) showed mostly leiomyomatous nodules that were necrotized, some of which were still viable. All 7 patients with menorrhagia had improvement of symptoms at the mid-term follow-up. The initial mean uterine volume was 601.30 ± 533.92 cm 3 and was decreased to a mean of 278.81 ± 202.70 cm 3 at 3 months follow-up, for a mean uterus volume reduction rate of 50.1{\%} (p < 0.05). One patient became pregnant 5 months after UAE treatment. Conclusion: UAE was a highly effective treatment for diffuse uterine leiomyomatosis with mid-term durability and may be a valuable alternative to hysterectomy.",
author = "Jieun Koh and Kim, {Man Deuk} and Jung, {Dae Chul} and Myungsu Lee and Lee, {Mu Sook} and Won, {Jong Yun} and Lee, {Do Yun} and Park, {Sung Il} and Lee, {Kwang Hun}",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.ejrad.2011.11.010",
language = "English",
volume = "81",
pages = "2726--2729",
journal = "European Journal of Radiology",
issn = "0720-048X",
publisher = "Elsevier Ireland Ltd",
number = "10",

}

Uterine artery embolization (UAE) for diffuse leiomyomatosis of the uterus : Clinical and imaging results. / Koh, Jieun; Kim, Man Deuk; Jung, Dae Chul; Lee, Myungsu; Lee, Mu Sook; Won, Jong Yun; Lee, Do Yun; Park, Sung Il; Lee, Kwang Hun.

In: European Journal of Radiology, Vol. 81, No. 10, 01.10.2012, p. 2726-2729.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Uterine artery embolization (UAE) for diffuse leiomyomatosis of the uterus

T2 - Clinical and imaging results

AU - Koh, Jieun

AU - Kim, Man Deuk

AU - Jung, Dae Chul

AU - Lee, Myungsu

AU - Lee, Mu Sook

AU - Won, Jong Yun

AU - Lee, Do Yun

AU - Park, Sung Il

AU - Lee, Kwang Hun

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Purpose: The aim of the current study was to evaluate the efficacy of uterine artery embolization (UAE) in the management of diffuse uterine leiomyomatosis with mid-term follow-up. Materials and methods: All patients who underwent UAE between 2008 and 2010 for symptomatic fibroids were analyzed. Among 360 cases, a total of 7 patients with diffuse uterine leiomyomatosis diagnosed based on MRI were included in this retrospective study. Patient ages ranged from 29 to 38 (mean 32.7) years. The median follow-up period was 16 (range; 6-31) months. The embolic agent was non-spherical polyvinyl alcohol particles. All patients underwent follow-up MRI at 3 months after UAE. Uterine volumes were calculated using MRI. Menorrhagia symptom changes were assessed at mid-term follow-up. Results: There were no technical failures to catheterize the uterine artery and no adverse events requiring therapy after UAE. Contrast-enhanced MRI showed complete necrosis of the leiomyomatous nodules in 5 patients (71%) 3 months after embolization. Two patients (28%) showed mostly leiomyomatous nodules that were necrotized, some of which were still viable. All 7 patients with menorrhagia had improvement of symptoms at the mid-term follow-up. The initial mean uterine volume was 601.30 ± 533.92 cm 3 and was decreased to a mean of 278.81 ± 202.70 cm 3 at 3 months follow-up, for a mean uterus volume reduction rate of 50.1% (p < 0.05). One patient became pregnant 5 months after UAE treatment. Conclusion: UAE was a highly effective treatment for diffuse uterine leiomyomatosis with mid-term durability and may be a valuable alternative to hysterectomy.

AB - Purpose: The aim of the current study was to evaluate the efficacy of uterine artery embolization (UAE) in the management of diffuse uterine leiomyomatosis with mid-term follow-up. Materials and methods: All patients who underwent UAE between 2008 and 2010 for symptomatic fibroids were analyzed. Among 360 cases, a total of 7 patients with diffuse uterine leiomyomatosis diagnosed based on MRI were included in this retrospective study. Patient ages ranged from 29 to 38 (mean 32.7) years. The median follow-up period was 16 (range; 6-31) months. The embolic agent was non-spherical polyvinyl alcohol particles. All patients underwent follow-up MRI at 3 months after UAE. Uterine volumes were calculated using MRI. Menorrhagia symptom changes were assessed at mid-term follow-up. Results: There were no technical failures to catheterize the uterine artery and no adverse events requiring therapy after UAE. Contrast-enhanced MRI showed complete necrosis of the leiomyomatous nodules in 5 patients (71%) 3 months after embolization. Two patients (28%) showed mostly leiomyomatous nodules that were necrotized, some of which were still viable. All 7 patients with menorrhagia had improvement of symptoms at the mid-term follow-up. The initial mean uterine volume was 601.30 ± 533.92 cm 3 and was decreased to a mean of 278.81 ± 202.70 cm 3 at 3 months follow-up, for a mean uterus volume reduction rate of 50.1% (p < 0.05). One patient became pregnant 5 months after UAE treatment. Conclusion: UAE was a highly effective treatment for diffuse uterine leiomyomatosis with mid-term durability and may be a valuable alternative to hysterectomy.

UR - http://www.scopus.com/inward/record.url?scp=84865269485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865269485&partnerID=8YFLogxK

U2 - 10.1016/j.ejrad.2011.11.010

DO - 10.1016/j.ejrad.2011.11.010

M3 - Article

C2 - 22154588

AN - SCOPUS:84865269485

VL - 81

SP - 2726

EP - 2729

JO - European Journal of Radiology

JF - European Journal of Radiology

SN - 0720-048X

IS - 10

ER -